- Home
- ADVB vs BOLT Comparison
ADVB vs BOLT Comparison
Compare ADVB & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- BOLT
- Stock Information
- Founded
- ADVB 2014
- BOLT 2015
- Country
- ADVB United States
- BOLT United States
- Employees
- ADVB N/A
- BOLT N/A
- Industry
- ADVB Medical Specialities
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- ADVB Health Care
- BOLT Health Care
- Exchange
- ADVB Nasdaq
- BOLT Nasdaq
- Market Cap
- ADVB 20.8M
- BOLT 16.8M
- IPO Year
- ADVB 2025
- BOLT 2021
- Fundamental
- Price
- ADVB $0.44
- BOLT $5.15
- Analyst Decision
- ADVB
- BOLT Buy
- Analyst Count
- ADVB 0
- BOLT 3
- Target Price
- ADVB N/A
- BOLT $47.50
- AVG Volume (30 Days)
- ADVB 2.3M
- BOLT 18.6K
- Earning Date
- ADVB 08-26-2025
- BOLT 08-14-2025
- Dividend Yield
- ADVB N/A
- BOLT N/A
- EPS Growth
- ADVB N/A
- BOLT N/A
- EPS
- ADVB N/A
- BOLT N/A
- Revenue
- ADVB N/A
- BOLT $4,167,000.00
- Revenue This Year
- ADVB N/A
- BOLT N/A
- Revenue Next Year
- ADVB N/A
- BOLT $13.62
- P/E Ratio
- ADVB N/A
- BOLT N/A
- Revenue Growth
- ADVB N/A
- BOLT N/A
- 52 Week Low
- ADVB $0.34
- BOLT $5.10
- 52 Week High
- ADVB $4.10
- BOLT $14.36
- Technical
- Relative Strength Index (RSI)
- ADVB N/A
- BOLT 35.00
- Support Level
- ADVB N/A
- BOLT $5.40
- Resistance Level
- ADVB N/A
- BOLT $5.98
- Average True Range (ATR)
- ADVB 0.00
- BOLT 0.31
- MACD
- ADVB 0.00
- BOLT -0.05
- Stochastic Oscillator
- ADVB 0.00
- BOLT 4.03
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.